287 related articles for article (PubMed ID: 38629065)
1. Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs.
Perrino M; Voulaz E; Balin S; Cazzato G; Fontana E; Franzese S; Defendi M; De Vincenzo F; Cordua N; Tamma R; Borea F; Aliprandi M; Airoldi M; Cecchi LG; Fazio R; Alloisio M; Marulli G; Santoro A; Di Tommaso L; Ingravallo G; Russo L; Da Rin G; Villa A; Della Bella S; Zucali PA; Mavilio D
Front Immunol; 2024; 15():1288045. PubMed ID: 38629065
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics, prognostic factors, and long-term outcomes associated with epithelial malignancies of the thymus: A 20-year single-institution experience.
Altshuler E; Mathavan A; Mathavan A; Krekora U; Mathavan M; Hones K; Daily K
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1750. PubMed ID: 36369906
[TBL] [Abstract][Full Text] [Related]
3. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center.
Okuma Y; Hosomi Y; Watanabe K; Yamada Y; Horio H; Maeda Y; Okamura T; Hishima T
BMC Cancer; 2014 May; 14():349. PubMed ID: 24885581
[TBL] [Abstract][Full Text] [Related]
5. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
Zhang Y; Yu L; Jing Y; Ke J
Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
[TBL] [Abstract][Full Text] [Related]
6. Pathological aspects of malignant and benign thymic disorders.
Müller-Hermelink HK; Marx A
Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
[TBL] [Abstract][Full Text] [Related]
7. Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.
Tateo V; Manuzzi L; De Giglio A; Parisi C; Lamberti G; Campana D; Pantaleo MA
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33260538
[TBL] [Abstract][Full Text] [Related]
8. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification.
Yamada Y
Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic and Therapy-Related Immune Complications in Thymic Malignancies.
Lippner EA; Lewis DB; Robinson WH; Katsumoto TR
Curr Treat Options Oncol; 2019 Jun; 20(7):62. PubMed ID: 31227926
[TBL] [Abstract][Full Text] [Related]
10. Unraveling the Immune Microenvironment of Thymic Epithelial Tumors: Implications for Autoimmunity and Treatment.
Masaoutis C; Palamaris K; Kokkali S; Levidou G; Theocharis S
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887212
[TBL] [Abstract][Full Text] [Related]
11. Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors.
Arbour KC; Naidoo J; Steele KE; Ni A; Moreira AL; Rekhtman N; Robbins PB; Karakunnel J; Rimner A; Huang J; Riely GJ; Hellmann MD
PLoS One; 2017; 12(8):e0182665. PubMed ID: 28771603
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia gravis with thymic epithelial tumour: a retrospective analysis of a Japanese database.
Nakajima J; Okumura M; Yano M; Date H; Onuki T; Haniuda M; Sano Y;
Eur J Cardiothorac Surg; 2016 May; 49(5):1510-5. PubMed ID: 26537756
[TBL] [Abstract][Full Text] [Related]
13. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.
Okumura M; Fujii Y; Shiono H; Inoue M; Minami M; Utsumi T; Kadota Y; Sawa Y
Gen Thorac Cardiovasc Surg; 2008 Apr; 56(4):143-50. PubMed ID: 18401674
[TBL] [Abstract][Full Text] [Related]
14. Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor.
Jing X; Zhu H; Li Y; Jia W; Zhai X; Li J; Yu J
Immunotherapy; 2022 Oct; 14(14):1097-1107. PubMed ID: 36093721
[TBL] [Abstract][Full Text] [Related]
15. Histotyping of Indian thymomas: A clinicopathologic study from north India.
Guleria P; Parshad R; Malik PS; Ray R; Pandey RM; Jain D
Indian J Med Res; 2019 Aug; 150(2):153-160. PubMed ID: 31670270
[TBL] [Abstract][Full Text] [Related]
16. The autoimmune regulator AIRE in thymoma biology: autoimmunity and beyond.
Marx A; Hohenberger P; Hoffmann H; Pfannschmidt J; Schnabel P; Hofmann HS; Wiebe K; Schalke B; Nix W; Gold R; Willcox N; Peterson P; Ströbel P
J Thorac Oncol; 2010 Oct; 5(10 Suppl 4):S266-72. PubMed ID: 20859117
[TBL] [Abstract][Full Text] [Related]
17. Molecular landscape of thymic epithelial tumors.
Prays J; Ortiz-Villalón C
Semin Diagn Pathol; 2022 Mar; 39(2):131-136. PubMed ID: 34272124
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis.
Thanner J; Bekos C; Veraar C; Janik S; Laggner M; Boehm PM; Schiefer AI; Müllauer L; Klepetko W; Ankersmit HJ; Moser B
Oncoimmunology; 2020 May; 9(1):1756130. PubMed ID: 32923112
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography radiomic feature analysis of thymic epithelial tumors: Differentiation of thymic epithelial tumors from thymic cysts and prediction of histological subtypes.
Zhao W; Ozawa Y; Hara M; Okuda K; Hiwatashi A
Jpn J Radiol; 2024 Apr; 42(4):367-373. PubMed ID: 38010596
[TBL] [Abstract][Full Text] [Related]
20. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
Li H; Ren B; Yu S; Gao H; Sun PL
BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
